Doxa AB (publ) (DOXA.ST)
SEK 0.35
(-1.82%)
SEK 0.35
(-1.82%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.7 Million SEK | 97.96% |
| 2022 | 4.9 Million SEK | 0.0% |
| 2021 | - SEK | 0.0% |
| 2020 | - SEK | 0.0% |
| 2019 | - SEK | -100.0% |
| 2018 | 4.99 Million SEK | 149.5% |
| 2017 | 2 Million SEK | -42.86% |
| 2016 | 3.5 Million SEK | -30.0% |
| 2015 | 5 Million SEK | 0.0% |
| 2014 | - SEK | -100.0% |
| 2013 | 5 Million SEK | 99900.0% |
| 2012 | 5000.00 SEK | -99.12% |
| 2011 | 567 Thousand SEK | -94.75% |
| 2010 | 10.8 Million SEK | 1309.0% |
| 2009 | 767 Thousand SEK | 11.64% |
| 2008 | 687 Thousand SEK | -96.56% |
| 2007 | 19.96 Million SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | - SEK | -3.39% |
| 2024 Q1 | 5.9 Million SEK | -39.18% |
| 2023 Q4 | 9.7 Million SEK | 38.57% |
| 2023 Q3 | 7 Million SEK | -4.11% |
| 2023 Q2 | 7.3 Million SEK | -3.95% |
| 2023 Q1 | 7.6 Million SEK | 55.1% |
| 2023 FY | 9.7 Million SEK | 97.96% |
| 2022 Q1 | 1.7 Million SEK | 0.0% |
| 2022 FY | 4.9 Million SEK | 0.0% |
| 2022 Q3 | 1.7 Million SEK | 21.43% |
| 2022 Q4 | 4.9 Million SEK | 188.24% |
| 2022 Q2 | 1.4 Million SEK | -17.65% |
| 2021 Q2 | 1.5 Million SEK | 0.0% |
| 2021 FY | - SEK | 0.0% |
| 2021 Q3 | - SEK | -100.0% |
| 2021 Q4 | - SEK | 0.0% |
| 2021 Q1 | - SEK | 0.0% |
| 2020 Q4 | - SEK | -100.0% |
| 2020 Q3 | 10 Million SEK | 0.0% |
| 2020 Q2 | 10 Million SEK | 100.0% |
| 2020 Q1 | 5 Million SEK | 0.0% |
| 2020 FY | - SEK | 0.0% |
| 2019 Q3 | - SEK | 0.0% |
| 2019 Q4 | - SEK | 0.0% |
| 2019 FY | - SEK | -100.0% |
| 2019 Q1 | 2 Million SEK | -59.92% |
| 2019 Q2 | - SEK | -100.0% |
| 2018 Q3 | 2 Million SEK | 0.0% |
| 2018 Q4 | 4.99 Million SEK | 149.5% |
| 2018 Q2 | 2 Million SEK | 0.0% |
| 2018 FY | 4.99 Million SEK | 149.5% |
| 2018 Q1 | 2 Million SEK | 0.0% |
| 2017 Q2 | 7.5 Million SEK | 7.14% |
| 2017 Q1 | 7 Million SEK | 100.0% |
| 2017 FY | 2 Million SEK | -42.86% |
| 2017 Q3 | 10.5 Million SEK | 40.0% |
| 2017 Q4 | 2 Million SEK | -80.95% |
| 2016 Q3 | - SEK | -100.0% |
| 2016 FY | 3.5 Million SEK | -30.0% |
| 2016 Q4 | 3.5 Million SEK | 0.0% |
| 2016 Q2 | 400 Thousand SEK | 0.0% |
| 2016 Q1 | - SEK | -100.0% |
| 2015 FY | 5 Million SEK | 0.0% |
| 2015 Q3 | - SEK | 0.0% |
| 2015 Q2 | - SEK | 0.0% |
| 2015 Q1 | - SEK | 0.0% |
| 2015 Q4 | 5 Million SEK | 0.0% |
| 2014 FY | - SEK | -100.0% |
| 2014 Q4 | - SEK | 0.0% |
| 2014 Q3 | - SEK | 0.0% |
| 2014 Q2 | - SEK | 0.0% |
| 2014 Q1 | - SEK | -100.0% |
| 2013 Q4 | 5 Million SEK | 0.0% |
| 2013 Q3 | - SEK | 0.0% |
| 2013 FY | 5 Million SEK | 99900.0% |
| 2013 Q2 | - SEK | 0.0% |
| 2012 Q4 | 5000.00 SEK | 0.0% |
| 2012 FY | 5000.00 SEK | -99.12% |
| 2011 FY | 567 Thousand SEK | -94.75% |
| 2010 FY | 10.8 Million SEK | 1309.0% |
| 2009 FY | 767 Thousand SEK | 11.64% |
| 2008 FY | 687 Thousand SEK | -96.56% |
| 2007 FY | 19.96 Million SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AddLife AB (publ) | 5.28 Billion SEK | 99.817% |
| Biotage AB (publ) | 150 Million SEK | 93.533% |
| Bonesupport Holding AB (publ) | 17.48 Million SEK | 44.521% |
| Elekta AB (publ) | 7.24 Billion SEK | 99.866% |
| iZafe Group AB (publ) | 3.17 Million SEK | -205.512% |
| Ortivus AB (publ) | 5.48 Million SEK | -76.975% |
| Ortivus AB (publ) | 5.48 Million SEK | -76.975% |
| Q-linea AB (publ) | 20.56 Million SEK | 52.832% |
| S2Medical AB (publ) | - SEK | -Infinity% |
| Synsam AB (publ) | 3.25 Billion SEK | 99.702% |